QTRX · Quanterix Corp · Executive Compensation
$3.15
+0.03 (+0.80%)
At close · Oct 29
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$147.55M
Shares
47.29M
Volume · Oct 29
334.18K
Avg daily vol (3M)
745.9K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Masoud Toloue | Ph.D. President and Chief Executive Officer | $6,433,027 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Masoud Toloue | Ph.D. President and Chief Executive Officer | $5,435,274 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Masoud Toloue | Ph.D. President and Chief Executive Officer | $2,957,026 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Kevin Hrusovsky | Executive Chairman and Former Chief Executive Officer Michael A. Doyle Chief Financial Officer | $4,208,194 |
| E. Kevin Hrusovsky | Executive Chairman and Former Chief Executive Officer | $4,208,194 |
| Masoud Toloue | Ph.D. President and Chief Executive Officer; Former President of Quanterix and Diagnostics | $3,638,963 |
| John Fry | General Counsel and Secretary | $1,145,941 |
| Dawn Mattoon | Senior Vice President, Clinical Diagnostics | $1,142,537 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| E. Kevin Hrusovsky | Executive Chairman and Former Chief Executive Officer | $3,520,397 |
| Kevin Hrusovsky | Executive Chairman and Former Chief Executive Officer Michael A. Doyle Chief Financial Officer | $3,520,397 |
| William Geist | Chief Operating Officer | $2,484,582 |
| Amol Chaubal | Chief Financial Officer | $1,226,920 |
| John Fry | General Counsel and Secretary | $1,225,073 |
| Dawn Mattoon | Senior Vice President, Clinical Diagnostics | $1,204,754 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| E. Kevin Hrusovsky | Executive Chairman and Former Chief Executive Officer | $3,630,996 |
| Kevin Hrusovsky | Executive Chairman and Former Chief Executive Officer Michael A. Doyle Chief Financial Officer | $3,630,996 |
| John Fry | General Counsel and Secretary | $1,685,282 |
| Amol Chaubal | Chief Financial Officer | $1,343,425 |
| Dawn Mattoon | Senior Vice President, Clinical Diagnostics | $885,613 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| E. Kevin Hrusovsky | Chairman, President and Chief Executive Officer | $5,547,580 |
| Kevin Hrusovsky | Chairman, President and Chief Executive Officer | $5,547,580 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jason Faessler | Chief Financial Officer and Treasurer | Appointed | 2026-06-09 |
| Anthony Catalano | Chief Operating Officer | Appointed | 2026-05-26 |
| Everett Cunningham | Class II director | Appointed | 2026-01-08 |
| Masoud Toloue | member of the Board of Directors | Resigned | 2026-01-08 |
| Everett Cunningham | President and Chief Executive Officer | Appointed | 2026-01-08 |
| Masoud Toloue | President and Chief Executive Officer | Resigned | 2026-01-08 |
| Alan Sachs | Board | Appointed | 2025-11-20 |
| William Donnelly | Executive Chair of the Board | Appointed | 2025-11-20 |
| David Walt | Board of Directors | Retired | 2025-11-20 |
| Garret Hampton | Board | Appointed | 2025-11-20 |
| Paul Meister | Board of Directors | Retired | 2025-11-20 |
| Myla Lai-Goldman, MD | Class II director | Appointed | 2025-07-08 |
| Scott Mendel | Class I director | Appointed | 2025-07-08 |
| Martin Madaus, Ph.D. | board of directors of Quanterix | Resigned | 2025-07-08 |
| Sarah Hlavinka | board of directors of Quanterix | Resigned | 2025-07-08 |
| William P. Donnelly | Chairman of the Board | Appointed | 2025-03-28 |
| Ivana Magovčević-Liebisch | Class III director | Appointed | 2024-10-03 |
| Jeffrey T. Elliott | Class I director | Appointed | 2024-08-21 |
| Daniel Pikora | Chief Operating Officer | Resigned | 2024-05-28 |
| Michael Miller | Chief Operating Officer | Appointed | 2024-05-28 |
| Brian J. Blaser | Board of Directors | Resigned | 2024-05-07 |
| William P. Donnelly | Class III director | Appointed | 2023-08-22 |
| Vandana Sriram | Chief Financial Officer | Appointed | 2023-08-09 |
| Keith L. Crandell | director | Retired | 2023-04-14 |
| Brian J. Blaser | Class III director | Appointed | 2023-01-09 |
Leadership
- Everett Cunningham CEO, Board Member
- Kevin Hrusovsky CEO, Chairman
- Masoud Toloue CEO, Chairman
- Martin D. Madaus Chairman
- William Donnelly Chairman
- William P. Donnelly Chairman, Board Member
- Jason Faessler CFO
- Michael Doyle CFO
- Vandana Sriram CFO
- Anthony Catalano COO
- Daniel Pikora COO
- Michael Miller COO
- David C. Duffy CTO
- John Fry General Counsel
- Alan Sachs Board Member
- Alan Sachs, M.D., Ph.D. Board Member
- Brian J. Blaser Board Member
- Garret Hampton Board Member
- Garret Hampton, Ph.D. Board Member
- Garret M. Hampton Board Member
- Ivana Magovčević-Liebisch Board Member
- Ivana Magovčević-Liebisch, Ph.D., J.D. Board Member
- Jeffrey T. Elliott Board Member
- Karen A. Flynn Board Member
- Laura J. Olson Board Member
- Myla Lai-Goldman Board Member
- Myla Lai-Goldman, MD Board Member
- Scott Mendel Board Member
Key facts
CIK
1503274
CUSIP
74766Q101
13F (30d)
18 filings
18 filers
Visit website
Investor relations